27 - CMV: Hope and Progress

Moderator(s)

• 

  Michael Angarone, DO (he/him/his)

  Associate Professor
  Internal Medicine
  Northwestern University Feinberg School of Medicine
  Chicago, IL, United States
• 

  Camille Kotton, MD, FIDSA, FAST

  Clinical Director, Transplant and Immunocompromised Host Infectious Diseases
  Infectious Diseases Division
  Massachusetts General Hospital
  Boston, Massachusetts, United States

Presentations:

• 10:30 AM - 10:42 AM US ET

  Risk Factors and Outcomes of Resistant CMV Infections in Hematopoietic Cell Transplant Recipients: a 7-Year Review
  

  Co-Author: Marilyne Daher, M.D. – Infectious Diseases, Infection Control, and Employee Health

  Co-Author: Jennifer Makhoul, MD (she/her/hers) – University of Texas Health Science Center at Houston/MD Anderson Cancer Center

  Co-Author: Vielka Lopez, n/a – The University of Texas MD Anderson Cancer Center

  Co-Author: Tali Shafat, MD – The University of Texas MD Anderson Cancer Center

  Co-Author: Amy Spallone, M.D. – University of Texas MD Anderson Cancer Center

  Co-Author: Terri Lynn Shigle, PharmD, BCOP – The University of Texas MD Anderson Cancer Center

  Co-Author: Joseph Sassine, MD – University of Oklahoma Health Sciences Center

  Co-Author: Anthony Febres, MD – The University of Texas at San Antonio

  Co-Author: Oscar Morado-Aramburo, MD – Hospital Beneficiencia Española

  Co-Author: Ella Ariza Heredia, MD – The University of Texas MD Anderson Cancer Center

  Presenting Author: Fareed Khawaja, MBBS – The University of Texas MD Anderson Cancer Center

  Co-Author: Roy F. Chemaly, MD/MPH (he/him/his) – University of Texas MD Anderson Cancer Center
• 10:42 AM - 10:54 AM US ET

  Frequency of Viral Monitoring to Detect Cytomegalovirus Infection and Prevent Disease in Solid Organ Transplant Recipients: An International Multicenter Study
  

  Presenting Author: Anja Lindis Dahl, MD – Rigshospitalet

  Co-Author: Oriol Manuel, MD – Lausanne University Hospital and University of Lausanne

  Co-Author: Kristian Schoenning, Senior doctor – Rigshospitalet

  Co-Author: Helene Høgsbro Thygesen, Biostatistician – Rigshospitalet

  Co-Author: Michael Perch, MD – University of Copenhagen

  Co-Author: Søren Scwartz Sørensen, Senior doctor – Rigshospitalet

  Co-Author: Nicolai Aagaard Schultz, Senior doctor – Rigshospitalet

  Co-Author: Kasper Rossing, Senior doctor – Rigshospitalet

  Co-Author: Jens Lundgren, MD DMSc – Rigshospitalet, University of Copenhagen

  Co-Author: Nicolas Johannes Müller, Professor – Zåurich University Hospital

  Co-Author: Marie Helleberg, PhD, DMSc – Rigshospitalet, Copenhagen University Hospital
• 10:54 AM - 11:06 AM US ET

  Refractory, Resistant and Recurrent Cytomegalovirus Infections in Solid Organ Transplant Recipients: Risk Factors and Clinical Outcomes
  

  Co-Author: Bismarck Bisono Garcia, MD (he/him/his) – Mayo Clinic

  Presenting Author: Benjo P. Ato, MD (he/him/his) – Philippine General Hospital

  Co-Author: Christopher A. Dinh, M.D. – Mayo Clinic

  Co-Author: Vaisak O. Nair, MD (he/him/his) – Mayo Clinic

  Co-Author: Zachary Yetmar, MD (he/him/his) – Cleveland Clinic

  Co-Author: Raymund R. Razonable, MD (he/him/his) – Mayo Clinic
• 11:06 AM - 11:18 AM US ET

  Letermovir as CMV Prophylaxis in Liver Transplant Recipients
  

  Co-Author: Emily A. Siegrist, PharmD – OU Health

  Co-Author: Phu Nguyen, PharmD – OU Health

  Co-Author: Rita Wilson Dib, MD – University of Oklahoma

  Presenting Author: Joseph Sassine, MD – University of Oklahoma Health Sciences Center
• 11:18 AM - 11:30 AM US ET

  Cytomegalovirus (CMV) Serostatus Reassessment for Accurate CMV Risk Stratification in CMV Seronegative Kidney Transplant Candidates
  

  Presenting Author: Ajmeet K. Pama-Ghuman (she/her/hers) – University of California, San Francisco (UCSF)

  Co-Author: Puneet Sood, MD, MPH – UCSF

  Co-Author: Monica Fung, MD, MPH – University of California San Francisco

  Co-Author: Lakshin Kumar, BS – University of California San Francisco

  Co-Author: Garrett R. Roll, MD – UCSF

  Co-Author: Anna Mello, MHA, CPHQ – UCSF

  Co-Author: Abhijit Limaye, M.D. – Univ of California San Francisco
• 11:30 AM - 11:43 AM US ET

  Interim Assessment of Safety and Immunogenicity From a Proof-of-Concept Phase 2 Trial of an mRNA-Based Cytomegalovirus Vaccine in Patients Who Have Undergone Allogeneic Hematopoietic Cell Transplantation
  

  Presenting Author: Nicolas C. Issa, MD – Brigham & Women's Hospital

  Co-Author: Jessica S. Little, MD (she/her/hers) – Brigham and Women's Hospital

  Co-Author: Jennifer Husson, MD – Moderna, Inc.

  Co-Author: Chunla He, PhD – Moderna, Inc.

  Co-Author: Benjamin Lorenz, MD – Moderna, Inc.

  Co-Author: Lindsey R. Baden, MD – Brigham and Women's Hospital

  Presenting Author: Lori Panther, MD, MPH – Moderna, Inc.